Compounded semaglutide program
Clinician-evaluated injectable or oral compounded semaglutide options advertised by the platform.
View provider sourceVirtual provider · Telehealth available
Provider overview
TelePep reports online care in 48 states and Washington, DC, excluding Alaska and Mississippi. This unclaimed profile is based on the company’s public website. The identity of its contracted medical group and individual treating clinicians was not independently established during this review, so state coverage and service details are labeled provider-reported.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Services advertised on the provider’s public website, organized by area of care.
Clinician-evaluated injectable or oral compounded semaglutide options advertised by the platform.
View provider sourceClinician-evaluated injectable or oral compounded tirzepatide options advertised by the platform.
View provider sourceA provider-advertised lower-dose GLP-1 track; eligibility and formulation require clinician review.
View provider sourceA GLP-1 evaluation track advertised for patients with PCOS or insulin-resistance concerns.
View provider sourcePrescription NAD+ delivery options advertised as part of the clinical-wellness track.
View provider sourcePhysician evaluation for sermorelin; the platform states that clinical appropriateness is determined individually.
View provider sourceAdditional prescription wellness offerings named on the provider’s public site.
View provider sourceA provider-advertised program using oral finasteride, topical minoxidil, and GHK-Cu serum.
View provider sourceOnline clinician review, prescription when appropriate, home delivery, and care-team messaging.
View provider sourceEvidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity and services · Checked Jul 20, 2026
Supports: states served · Checked Jul 20, 2026
Supports: care model and services · Checked Jul 20, 2026